BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26975374)

  • 41. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
    Claij N; Te Riele H
    Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of insertion/deletion DNA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3.
    Habraken Y; Sung P; Prakash L; Prakash S
    Curr Biol; 1996 Sep; 6(9):1185-7. PubMed ID: 8805366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
    Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
    Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.
    DeWeese TL; Shipman JM; Larrier NA; Buckley NM; Kidd LR; Groopman JD; Cutler RG; te Riele H; Nelson WG
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11915-20. PubMed ID: 9751765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Saccharomyces cerevisiae MSH2-MSH3 and MSH2-MSH6 complexes display distinct requirements for DNA binding domain I in mismatch recognition.
    Lee SD; Surtees JA; Alani E
    J Mol Biol; 2007 Feb; 366(1):53-66. PubMed ID: 17157869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells.
    Claij N; te Riele H
    Oncogene; 2004 Jan; 23(1):260-6. PubMed ID: 14712231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.
    Yang Q; Laknaur A; Elam L; Ismail N; Gavrilova-Jordan L; Lue J; Diamond MP; Al-Hendy A
    Reprod Sci; 2016 Oct; 23(10):1314-25. PubMed ID: 27036951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A role for mismatch repair in control of DNA ploidy following DNA damage.
    Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R
    Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Msh2 separation of function mutations confer defects in the initiation steps of mismatch repair.
    Kijas AW; Studamire B; Alani E
    J Mol Biol; 2003 Aug; 331(1):123-38. PubMed ID: 12875840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity.
    Christmann M; Tomicic MT; Kaina B
    Nucleic Acids Res; 2002 May; 30(9):1959-66. PubMed ID: 11972333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HuCOP1 contributes to the regulation of DNA repair in keratinocytes.
    Fazekas B; Carty MP; Németh I; Kemény L; Széll M; Ádám É
    Mol Cell Biochem; 2017 Mar; 427(1-2):103-109. PubMed ID: 27995412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
    Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
    Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of Msh2 knockdown on toxicity induced by tert-butyl-hydroperoxide, potassium bromate, and hydrogen peroxide in base excision repair proficient and deficient cells.
    Cooley N; Elder RH; Povey AC
    Biomed Res Int; 2013; 2013():152909. PubMed ID: 23984319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homologous recombination rescues mismatch-repair-dependent cytotoxicity of S(N)1-type methylating agents in S. cerevisiae.
    Cejka P; Mojas N; Gillet L; Schär P; Jiricny J
    Curr Biol; 2005 Aug; 15(15):1395-400. PubMed ID: 16085492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The DNA-mismatch repair enzyme hMSH2 modulates UV-B-induced cell cycle arrest and apoptosis in melanoma cells.
    Seifert M; Scherer SJ; Edelmann W; Böhm M; Meineke V; Löbrich M; Tilgen W; Reichrath J
    J Invest Dermatol; 2008 Jan; 128(1):203-13. PubMed ID: 17611581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
    Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Senescence-dependent MutS alpha dysfunction attenuates mismatch repair.
    Chang IY; Jin M; Yoon SP; Youn CK; Yoon Y; Moon SP; Hyun JW; Jun JY; You HJ
    Mol Cancer Res; 2008 Jun; 6(6):978-89. PubMed ID: 18567801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-tumor cells from an MSH2-null individual show altered cell cycle effects post-UVB.
    Narine KA; Felton KE; Parker AA; Tron VA; Andrew SE
    Oncol Rep; 2007 Dec; 18(6):1403-11. PubMed ID: 17982623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.